BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

9661 related articles for article (PubMed ID: 19675859)

  • 1. Can gallium-68 compounds partly replace (18)F-FDG in PET molecular imaging?
    Pagou M; Zerizer I; Al-Nahhas A
    Hell J Nucl Med; 2009; 12(2):102-5. PubMed ID: 19675859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 68Ga-PET: a powerful generator-based alternative to cyclotron-based PET radiopharmaceuticals.
    Fani M; André JP; Maecke HR
    Contrast Media Mol Imaging; 2008; 3(2):67-77. PubMed ID: 18383558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of (68)Ge/(68)Ga generator processing by chemical purification for routine clinical application of (68)Ga-DOTATOC.
    Asti M; De Pietri G; Fraternali A; Grassi E; Sghedoni R; Fioroni F; Roesch F; Versari A; Salvo D
    Nucl Med Biol; 2008 Aug; 35(6):721-4. PubMed ID: 18678358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Convenient preparation of 68Ga-based PET-radiopharmaceuticals at room temperature.
    Velikyan I; Maecke H; Langstrom B
    Bioconjug Chem; 2008 Feb; 19(2):569-73. PubMed ID: 18205327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 99mTc-EC-deoxyglucose-- poor man's 18F-FDG: what will be the future of PET in molecular imaging?
    Uz Zaman M
    Eur J Nucl Med Mol Imaging; 2007 Mar; 34(3):429. PubMed ID: 17143646
    [No Abstract]   [Full Text] [Related]  

  • 6. 68Ga-labeled oligonucleotides for in vivo imaging with PET.
    Roivainen A; Tolvanen T; Salomäki S; Lendvai G; Velikyan I; Numminen P; Välilä M; Sipilä H; Bergström M; Härkönen P; Lönnberg H; Långström B
    J Nucl Med; 2004 Feb; 45(2):347-55. PubMed ID: 14960659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of unusual neuroendocrine tumours by means of 68Ga-DOTA-NOC PET.
    Fanti S; Ambrosini V; Tomassetti P; Castellucci P; Montini G; Allegri V; Grassetto G; Rubello D; Nanni C; Franchi R
    Biomed Pharmacother; 2008 Dec; 62(10):667-71. PubMed ID: 18358680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical indications for Gallium-68 positron emission tomography imaging.
    Khan MU; Khan S; El-Refaie S; Win Z; Rubello D; Al-Nahhas A
    Eur J Surg Oncol; 2009 Jun; 35(6):561-7. PubMed ID: 19201567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Operational radiation safety for PET-CT, SPECT-CT, and cyclotron facilities.
    Zanzonico P; Dauer L; St Germain J
    Health Phys; 2008 Nov; 95(5):554-70. PubMed ID: 18849690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility and availability of ⁶⁸Ga-labelled peptides.
    Decristoforo C; Pickett RD; Verbruggen A
    Eur J Nucl Med Mol Imaging; 2012 Feb; 39 Suppl 1():S31-40. PubMed ID: 22388621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of SnO2-based 68Ge/68Ga generator and aspects of radiolabelling DOTA-peptides.
    de Blois E; Sze Chan H; Naidoo C; Prince D; Krenning EP; Breeman WA
    Appl Radiat Isot; 2011 Feb; 69(2):308-15. PubMed ID: 21145751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acyclic chelate with ideal properties for (68)Ga PET imaging agent elaboration.
    Boros E; Ferreira CL; Cawthray JF; Price EW; Patrick BO; Wester DW; Adam MJ; Orvig C
    J Am Chem Soc; 2010 Nov; 132(44):15726-33. PubMed ID: 20958034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (68)Ga-labeled peptides in tumor imaging.
    Maecke HR; Hofmann M; Haberkorn U
    J Nucl Med; 2005 Jan; 46 Suppl 1():172S-8S. PubMed ID: 15653666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (68)Ge/ (68)Ga generators: past, present, and future.
    Rösch F
    Recent Results Cancer Res; 2013; 194():3-16. PubMed ID: 22918751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation of ⁶⁸Ga-labelled DOTA-peptides using a manual labelling approach for small-animal PET imaging.
    Romero E; Martínez A; Oteo M; García A; Morcillo MA
    Appl Radiat Isot; 2016 Jan; 107():113-120. PubMed ID: 26492321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of single vial kits for preparation of (68)Ga-labelled peptides for PET imaging of neuroendocrine tumours.
    Mukherjee A; Pandey U; Chakravarty R; Sarma HD; Dash A
    Mol Imaging Biol; 2014 Aug; 16(4):550-7. PubMed ID: 24477930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The diversity of (68)Ga-based imaging agents.
    Velikyan I
    Recent Results Cancer Res; 2013; 194():101-31. PubMed ID: 22918757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PET imaging in endocrine tumours.
    Khan S; Lloyd C; Szyszko T; Win Z; Rubello D; Al-Nahhas A
    Minerva Endocrinol; 2008 Jun; 33(2):41-52. PubMed ID: 18414356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Past, present and future of 68Ge/68Ga generators.
    Rösch F
    Appl Radiat Isot; 2013 Jun; 76():24-30. PubMed ID: 23245638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positron emission tomography (PET) and macromolecular delivery in vivo.
    Strauss LG; Dimitrakopoulou-Strauss A
    Methods Mol Biol; 2009; 480():187-98. PubMed ID: 19085122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 484.